1. Home
  2. CRL vs APGE Comparison

CRL vs APGE Comparison

Compare CRL & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

N/A

Current Price

$288.50

Market Cap

10.8B

Sector

Health Care

ML Signal

N/A

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$135.07

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRL
APGE
Founded
1947
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.8B
10.2B
IPO Year
1999
2023

Fundamental Metrics

Financial Performance
Metric
CRL
APGE
Price
$288.50
$135.07
Analyst Decision
Buy
Strong Buy
Analyst Count
12
13
Target Price
$198.27
$109.67
AVG Volume (30 Days)
848.5K
1.3M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,857,601,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.48
N/A
52 Week Low
$144.26
$35.39
52 Week High
$303.31
$135.09

Technical Indicators

Market Signals
Indicator
CRL
APGE
Relative Strength Index (RSI) 61.92 78.58
Support Level $215.89 $134.03
Resistance Level $303.31 N/A
Average True Range (ATR) 9.54 0.10
MACD -2.67 -0.39
Stochastic Oscillator 43.54 96.88

Price Performance

Historical Comparison
CRL
APGE

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: